Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1954 1
1961 1
1968 3
1969 1
1970 1
1971 1
1973 2
1974 1
1976 1
1978 1
1979 1
1980 7
1981 6
1982 1
1983 6
1984 4
1985 2
1986 4
1987 7
1988 8
1989 16
1990 18
1991 14
1992 11
1993 17
1994 2
1995 4
1996 5
1997 3
1998 3
1999 3
2000 7
2001 6
2002 1
2003 4
2004 3
2005 5
2006 9
2007 10
2008 4
2009 4
2010 2
2011 6
2012 6
2013 5
2014 13
2015 9
2016 9
2017 9
2018 10
2019 10
2020 12
2021 11
2022 11
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Results by year

Filters applied: . Clear all
Page 1
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Paik PK, Felip E, Veillon R, Sakai H, Cortot AB, Garassino MC, Mazieres J, Viteri S, Senellart H, Van Meerbeeck J, Raskin J, Reinmuth N, Conte P, Kowalski D, Cho BC, Patel JD, Horn L, Griesinger F, Han JY, Kim YC, Chang GC, Tsai CL, Yang JC, Chen YM, Smit EF, van der Wekken AJ, Kato T, Juraeva D, Stroh C, Bruns R, Straub J, Johne A, Scheele J, Heymach JV, Le X. Paik PK, et al. Among authors: bruns r. N Engl J Med. 2020 Sep 3;383(10):931-943. doi: 10.1056/NEJMoa2004407. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469185 Free PMC article. Clinical Trial.
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial.
Mazieres J, Paik PK, Garassino MC, Le X, Sakai H, Veillon R, Smit EF, Cortot AB, Raskin J, Viteri S, Wu YL, Yang JCH, Ahn MJ, Ma R, Zhao J, O'Brate A, Berghoff K, Bruns R, Otto G, Johne A, Felip E, Thomas M. Mazieres J, et al. Among authors: bruns r. JAMA Oncol. 2023 Sep 1;9(9):1260-1266. doi: 10.1001/jamaoncol.2023.1962. JAMA Oncol. 2023. PMID: 37270698 Free PMC article. Clinical Trial.
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.
Le X, Sakai H, Felip E, Veillon R, Garassino MC, Raskin J, Cortot AB, Viteri S, Mazieres J, Smit EF, Thomas M, Iams WT, Cho BC, Kim HR, Yang JC, Chen YM, Patel JD, Bestvina CM, Park K, Griesinger F, Johnson M, Gottfried M, Britschgi C, Heymach J, Sikoglu E, Berghoff K, Schumacher KM, Bruns R, Otto G, Paik PK. Le X, et al. Among authors: bruns r. Clin Cancer Res. 2022 Mar 15;28(6):1117-1126. doi: 10.1158/1078-0432.CCR-21-2733. Clin Cancer Res. 2022. PMID: 34789481 Free PMC article. Clinical Trial.
Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis.
Liam CK, Ahmad AR, Hsia TC, Zhou J, Kim DW, Soo RA, Cheng Y, Lu S, Shin SW, Yang JC, Zhang Y, Zhao J, Berghoff K, Bruns R, Johne A, Wu YL. Liam CK, et al. Among authors: bruns r. Clin Cancer Res. 2023 May 15;29(10):1879-1886. doi: 10.1158/1078-0432.CCR-22-3318. Clin Cancer Res. 2023. PMID: 36971777 Free PMC article. Clinical Trial.
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial.
Wu YL, Cheng Y, Zhou J, Lu S, Zhang Y, Zhao J, Kim DW, Soo RA, Kim SW, Pan H, Chen YM, Chian CF, Liu X, Tan DSW, Bruns R, Straub J, Johne A, Scheele J, Park K, Yang JC; INSIGHT Investigators. Wu YL, et al. Among authors: bruns r. Lancet Respir Med. 2020 Nov;8(11):1132-1143. doi: 10.1016/S2213-2600(20)30154-5. Epub 2020 May 29. Lancet Respir Med. 2020. PMID: 32479794 Clinical Trial.
Special issue - VIII Brazilian Chemometrics Workshop.
Ferreira SLC, Scarminio IS, Almeida Bezerra M, Sena MM, Ferreira MMC, Pimentel MF, Bruns RE, Lemos SG, Fragoso WD, Santos WNLD. Ferreira SLC, et al. Among authors: bruns re. Food Chem. 2019 Feb 1;273:1-2. doi: 10.1016/j.foodchem.2018.07.088. Epub 2018 Jul 17. Food Chem. 2019. PMID: 30292354 No abstract available.
Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B.
Le X, Paz-Ares LG, Van Meerbeeck J, Viteri S, Galvez CC, Smit EF, Garassino M, Veillon R, Baz DV, Pradera JF, Sereno M, Kozuki T, Kim YC, Yoo SS, Han JY, Kang JH, Son CH, Choi YJ, Stroh C, Juraeva D, Vioix H, Bruns R, Otto G, Johne A, Paik PK. Le X, et al. Among authors: bruns r. Cell Rep Med. 2023 Nov 21;4(11):101280. doi: 10.1016/j.xcrm.2023.101280. Epub 2023 Nov 8. Cell Rep Med. 2023. PMID: 37944528 Free PMC article.
Adenosine receptors. Roles and pharmacology.
Bruns RF. Bruns RF. Ann N Y Acad Sci. 1990;603:211-25; discussion 225-6. doi: 10.1111/j.1749-6632.1990.tb37674.x. Ann N Y Acad Sci. 1990. PMID: 2291523 Review. No abstract available.
Measuring the Burden of Infodemics: Summary of the Methods and Results of the Fifth WHO Infodemic Management Conference.
Wilhelm E, Ballalai I, Belanger ME, Benjamin P, Bertrand-Ferrandis C, Bezbaruah S, Briand S, Brooks I, Bruns R, Bucci LM, Calleja N, Chiou H, Devaria A, Dini L, D'Souza H, Dunn AG, Eichstaedt JC, Evers SMAA, Gobat N, Gissler M, Gonzales IC, Gruzd A, Hess S, Ishizumi A, John O, Joshi A, Kaluza B, Khamis N, Kosinska M, Kulkarni S, Lingri D, Ludolph R, Mackey T, Mandić-Rajčević S, Menczer F, Mudaliar V, Murthy S, Nazakat S, Nguyen T, Nilsen J, Pallari E, Pasternak Taschner N, Petelos E, Prinstein MJ, Roozenbeek J, Schneider A, Srinivasan V, Stevanović A, Strahwald B, Syed Abdul S, Varaidzo Machiri S, van der Linden S, Voegeli C, Wardle C, Wegwarth O, White BK, Willie E, Yau B, Purnat TD. Wilhelm E, et al. Among authors: bruns r. JMIR Infodemiology. 2023 Feb 20;3:e44207. doi: 10.2196/44207. eCollection 2023. JMIR Infodemiology. 2023. PMID: 37012998 Free PMC article.
315 results